Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 3821-3830 of 13149

Page
per page
  1. Zoliflodacin
    BA1032 Zoliflodacin
    Summary: Zoliflodacin (ETX0914; AZD0914) is a novel helical pyrimidine triad, inhibitor.
      ≥52 mg/mL
  2. 4-Fluororesorcinol
    C8295 4-Fluororesorcinol
    Summary: 4-Fluororesorcinol is a precursor.
  3. CDK9-IN-7
    BA2986 CDK9-IN-7
    Summary: CDK9-IN-7 is a highly potent and selective, orally active inhibitor.
  4. BML-278
    BA4522 BML-278
    Summary: BML-278 is an activator.
  5. L-(+)-Ergothioneine
    C5158 L-(+)-Ergothioneine
    Summary: An antioxidant that can selectively inhibit the p38-MAPK and Akt pathways.
      insoluble in DMSO; insoluble in EtOH; ≥5.2 mg/mL
  6. Boc-D-N-Me-Phe.DCHA
    A7707 Boc-D-N-Me-Phe.DCHA
  7. Nifurpirinol
    BA1031 Nifurpirinol
    Summary: NTR substrate; for regeneration research and FSGS disease modeling
      ≥42.2 mg/mL
  8. DND-189
    C8294 DND-189
    Summary: DND-189 is a low pH fluorescent probe that is sensitive to neutral and low pH ranges.
  9. Thalidomide-O-PEG2-propargyl
    BA2985 Thalidomide-O-PEG2-propargyl
    Summary: Thalidomide-O-PEG2-propargyl (E3ligaseLigand-LinkerConjugates32) is a synthesized E3 ligase ligand-linker coupler comprising a Thalidomide-based ligand and a 2-unit PEG linker for technical applications.
  10. SIRT2-IN-11
    BA4521 SIRT2-IN-11
    Summary: SIRT2-IN-11 (AEM1) is a selective inhibitor.

Items 3821-3830 of 13149

Page
per page